Načítá se...
Breakthrough Therapies: Cystic Fibrosis (CF) Potentiators and Correctors
Cystic Fibrosis is caused by mutations in the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) gene resulting in abnormal protein function. Recent advances of targeted molecular therapies and high throughput screening have resulted in multiple drug therapies that target many important muta...
Uloženo v:
| Vydáno v: | Pediatr Pulmonol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4620567/ https://ncbi.nlm.nih.gov/pubmed/26097168 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ppul.23240 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|